Eye News and Research

Latest Eye News and Research

Submacular air injection aids tPA haemorrhage displacement

Submacular air injection with a microneedle is effective at facilitating the displacement of massive submacular haemorrhages dissolved with tissue plasminogen activator in patients with age-related macular degeneration, an interventional case series shows.

20 May 2015

Heavy metallic elements influence AMD progression

Researchers report associations between age-related macular degeneration and five heavy metallic elements, in findings that highlight the detrimental effects of pollution but the possible benefits of essential elements supplementation.

20 May 2015

AMD severity and progression tracks across eyes

Age-related macular degeneration in one eye tracks the severity of it in the fellow eye at all stages of the disease, findings from the Beaver Dam Eye study show.

20 May 2015

Scientists find key to light-induced color change in fish skin

The neon tetra fish from the Amazonas River, along with some reptiles, amphibians, and other fish, takes advantage of structural colors in its skin to change its appearance in response to a triggering signal. In the light-adapted state, its lateral stripe shimmers blue-green, in the dark it is indigo. Scientists from Israel have now found an unambiguous answer to how this intriguing mechanism works. They present their results, which favor the so-called "Venetian blind" model, in the journal Angewandte Chemie.

20 May 2015

No added benefit with pazopanib over ranibizumab for neovascular AMD

Pazopanib eye drops do not enhance visual outcomes in patients with neovascular age-related macular degeneration beyond those achieved with ranibizumab alone, study findings indicate.

19 May 2015

Promising preliminary results for AKB-9778 in diabetic macular oedema

AKB-9778, a small molecule competitive inhibitor of vascular endothelial-protein tyrosine phosphatase, has a good safety and efficacy profile in patients with diabetic macular oedema, suggests a preliminary dose-escalation study.

19 May 2015

Risk factors predict geographic atrophy after anti-VEGF treatment of RAP

Researchers have found three factors that could identify which patients with retinal angiomatous proliferation receiving anti-vascular endothelial growth factor treatment are likely to develop geographic atrophy.

19 May 2015

hESC-derived cells offer source of macular tissue repair and replacement

Subretinal transplantation of retinal pigment epithelium derived from human embryonic stem cells appears to be a well-tolerated means of treating age-related macular degeneration and Stargardt’s macular dystrophy, suggest two open-label phase I/II studies.

19 May 2015

California PACE enrollment continues to rise

Enrollment in the California Program for All-Inclusive Care for the Elderly (PACE) nearly doubled during the last four-and-a-half years based on the latest numbers reported from 11 programs operating 30 PACE centers in the state.

19 May 2015

U.K Ophthalmologists lead in treatment of wet AMD patients with Oraya therapy across europe

Oraya Therapy was introduced first in the U.K., followed by Switzerland and Germany. The therapy is intended as a one-time, non-invasive treatment that maintains vision with fewer anti-vascular endothelial growth factor (anti-VEGF) injections into the eye...

19 May 2015

Griffith students providing healthcare in Malawi

Malawi was the recent destination for a group of Griffith Health students who found that they could learn more from the disadvantaged local people than they had ever imagined.

19 May 2015

Asthma Ally app allows patients to connect with allergist's office for assistance

The adage, "There's an app for that" is even more true in light of an app that sends an alert to your allergist's office when your asthma may be out of control.

15 May 2015

Novel computer-aided system developed for acute stroke detection

The Hong Kong Polytechnic University has developed a novel computer-aided detection system for acute stroke using computer intelligence technology. Reading 80-100 computer images, the system is able to detect if the patient was struck by ischemic stroke or haemorrhagic stroke.

14 May 2015

Envision presents awards for work in low vision rehabilitation

Envision presents the Lifetime Achievement Award from time-to-time to researchers whose careers have been marked by outstanding, creative and important contributions to low vision research...

14 May 2015

Obese people at greater risk of developing cancer

Cancer is more likely to develop in people who are very overweight (obese), because surplus body fat interferes with various hormone cycles and with glucose and fat metabolism. On the occasion of European Obesity Day this coming Saturday (16 May), metabolic expert Alexandra Kautzky-Willer, Comprehensive Cancer Center at MedUni Vienna and Vienna General Hospital, draws attention to the fact that, even in Austria, more and more people are suffering from obesity.

12 May 2015

Touch surgery awarded Rising Star award at Founders Forum

The accolade of Smart Nation Rising Star comes on the heels a public announcement that the Touch Surgery app is now used by over 200,000 surgeons in every country on earth...

12 May 2015

UC Irvine study opens door to novel treatments for people with retinal damage

Driving down a dimly lit road at midnight can tax even those with 20/20 vision, but according to a recent UC Irvine study, the brain processes the experience no differently than if it were noon. The same study also reveals how quickly the brain adapts to vision loss, contradicting earlier research and opening the door to novel treatments.

12 May 2015

Myopia on the rise across Europe, new study finds

Myopia or short-sightedness is becoming more common across Europe, according to a new study led by King's College London. The meta-analysis of findings from 15 studies by the European Eye Epidemiology Consortium found that around a quarter of the European population is short-sighted but it is nearly twice as common in younger people, with almost half (47 per cent) of the group aged between 25 and 29 years affected.

12 May 2015

Dana-Farber/Boston Children's joins immunotherapy clinical trial for children with ALL

Dana-Farber/Boston Children's Cancer and Blood Disorders Center has joined a clinical trial of immunotherapy for children with relapsed or treatment-resistant acute lymphoblastic leukemia (ALL). Led by Memorial Sloan Kettering Cancer Center, the trial is one of several nationally that are evaluating cancer immunotherapy, a treatment approach -- hailed by Science magazine as their Breakthrough of the Year in 2013 -- that triggers a patient's immune system to attack his or her cancer cells.

11 May 2015

RBD persists in Parkinson’s disease patients

Symptoms of rapid eye movement sleep behaviour disorder (RBD) are unlikely to resolve in patients with Parkinson’s disease, show the findings of a 3-year study.

8 May 2015